nejm semaglutide ckd βοΈβπA pathbreaking trial published in @NEJM today πFLOW Trial πin Diabetic π«‘Significant benefits in renal and cardiovascular outcomes @ERAkidney #ERA24 @NEJM FLOWing with the SemagluTIDE β
Description
GLP-1 receptor agonists have become a cornerstone of modern weight management, but they aren't prescribed to everyone
But while the number on the scale may be dropping, the skin often tells its own story
GLP-1GIPGLP-1
Learn how these weight loss medications work, potential benefits, and safety risks.
A Few Things to Know: Everyones experience is different
